enow.com Web Search

  1. Ad

    related to: genentech humulin drug study

Search results

  1. Results from the WOW.Com Content Network
  2. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]

  3. Insulin (medication) - Wikipedia

    en.wikipedia.org/wiki/Insulin_(medication)

    Genentech developed the technique used to produce the first such insulin, Humulin, but did not commercially market the product themselves. Eli Lilly marketed Humulin in 1982. [28] Humulin was the first medication produced using modern genetic engineering techniques in which actual human DNA is inserted into a host cell (E. coli in this case ...

  4. Timeline of biotechnology - Wikipedia

    en.wikipedia.org/wiki/Timeline_of_biotechnology

    1982 – Humulin, Genentech's human insulin drug produced by genetically engineered bacteria for the treatment of diabetes, is the first biotech drug to be approved by the Food and Drug Administration. 1983 – The Polymerase Chain Reaction (PCR) technique is conceived.

  5. Genentech's Obinutuzumab (GA101) Significantly Reduced ... - AOL

    www.aol.com/2013/05/15/genentechs-obinutuzumab...

    Genentech's Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer Phase III data from the CLL11 study to ...

  6. History of genetic engineering - Wikipedia

    en.wikipedia.org/wiki/History_of_genetic_engineering

    Genentech announced the production of genetically engineered human insulin in 1978. [75] In 1980 the U.S. Supreme Court in the Diamond v. Chakrabarty case ruled that genetically altered life could be patented. [76] The insulin produced by bacteria, branded humulin, was approved for release by the Food and Drug Administration in 1982. [77]

  7. Arthur Riggs (geneticist) - Wikipedia

    en.wikipedia.org/wiki/Arthur_Riggs_(geneticist)

    Arthur Dale Riggs (August 8, 1939 – March 23, 2022) [1] was an American geneticist who worked with Genentech to express the first artificial gene in bacteria.His work was critical to the modern biotechnology industry because it was the first use of molecular techniques in commercial production of drugs [2] and enabled the large-scale manufacturing of protein drugs, including insulin.

  8. FDA Approves Genentech's Kadcyla (Ado-Trastuzumab ... - AOL

    www.aol.com/news/2013-02-22-fda-approves...

    FDA Approves Genentech's Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody-Drug Conjugate for Treating HER2-Positive Metastatic Breast Cancer -- New Personalized Medicine Helped People in ...

  9. Timeline of the history of genetics - Wikipedia

    en.wikipedia.org/wiki/Timeline_of_the_history_of...

    1982: The U.S. Food and Drug Administration (FDA) approved the release of the first genetically engineered human insulin, originally biosynthesized using recombination DNA methods by Genentech in 1978. [54] Once approved, the cloning process lead to mass production of humulin (under license by Eli Lilly & Co.).

  1. Ad

    related to: genentech humulin drug study